Atenolol/Nitrendipine

阿替洛尔/尼群地平

Report date: 2024/04/02 16:01:30

Base Information

Drug NameAtenolol/Nitrendipine
Drug Alias Name尼群洛尔片nitrendipine + atenolol
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelAdrenergic receptors
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaEssential Hypertension
Original Approved Country/TerritoryMainland China
Original Approved Date2009/01/01
Country/TerritoryMainland China
CombinationsYes AtenololNitrendipine
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJiangsu Giber Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Giber Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A